A Randomized Multicenter Study of Daylight Mediated Photodynamic Therapy (PDT)

Bispebjerg Hospital150 enrolled

Overview

A randomised, multi-center study of daylight mediated photodynamic therapy (PDT) with Metvix in patients with multiple actinic keratosis on the face and/or scalp.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

150

Conditions

Actinic Keratoses

Interventions

Photodynamic therapy with methyl aminolevulinatePROCEDURE

daylight mediated photodynamic therapy

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years and older, 5 AK in face and scalp Exclusion Criteria: * immunosuppression

Locations (1)

Bispebjerg Hospital

Copenhagen, Denmark

Outcomes

Primary Outcomes

response rate

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.